Hyperkalemia

Metabolic·MeSH: Hyperkalemia

5 drugs in development·4 companies·4 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Bumetanide for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
kionex	ANI PHARMACEUTICALS INC (ANIP)

Phase 3(2)

Drug	Company
patiromer powder for	Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)
patiromer powder for orals	Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)

Phase 2(1)

Drug	Company
RDX013	ARDELYX, INC. (ARDX)

BioSniper tracks 5 drugs in development for Hyperkalemia across 4 companies.

There are 4 clinical trials targeting Hyperkalemia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.